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Background/Aims: A flexible spectral imaging color en-
hancement system was installed in new capsule software for 
video capsule endoscopy. Contrast image capsule endosco-
py (CICE) is a novel technology using light-emitting diodes se-
lected for the main absorption range of hemoglobin. We as-
sessed the feasibility and diagnostic efﬁ  cacy for small bowel 
surveillance in patients with polyposis syndromes. Methods: 
Six patients with polyposis syndromes, four with familial ad-
enomatous polyposis and one each with Cowden syndrome 
(CS) and Cronkhite-Canada syndrome (CCS) were examined 
using CICE. We conducted three evaluations to assess the 
effect on the numbers of the detected polyps; compare polyp 
diagnostic rates between adenoma and hamartoma; and as-
sess polyp visibility. Results: The numbers of detected polyps 
and diagnostic accuracy did not differ signiﬁ  cantly between 
pre-contrast and contrast images. However, 50% of the ad-
enomatous polyps displayed enhanced visibility on contrast 
images. CICE contrast images exhibited clearly demarcated 
lesions and improved the visibility of minute structures of ad-
enomatous polyps. Hamartomatous polyp micro-structures 
in patients with CS and CCS were more clearly visualized on 
contrast than pre-contrast images. Conclusions: CICE is an 
effective tool for enhancing the visibility of polyps in patients 
with polyposis syndrome. (Gut Liver 2012;6:218-222)
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INTRODUCTION
Video capsule endoscopy (VCE) was first reported by Iddan 
et al.
1 in 2000. VCE allows visualization of the small intestinal 
mucosa and facilitates detection of small intestinal abnormali-
ties. Several studies have shown VCE to be extremely valuable 
for certain disorders, such as obscure gastrointestinal bleeding,
2 
suspected Crohn’s disease (CD),
3,4 small bowel tumors,
5 and small 
intestinal mucosal injury associated with the use of nonsteroidal 
anti-inflammatory drugs.
6 The efficacy of VCE for surveillance 
of small intestinal polyps in patients with polyposis syndromes 
has also been reported.
7-14
In the decade since its introduction, VCE has been improved 
in terms of systems and protocols, such as angle of view, analy-
sis software, pro-kinetics and bowel preparation. In conven-
tional endoscopy, development of narrow band imaging (NBI) 
and flexible spectral imaging color enhancement (FICE) systems 
improved visualization of minute micro-vascular patterns and 
mucosal structures. Some reports have suggested the efficacy of 
magnifying endoscopy with NBI and FICE for predicting histo-
logical characteristics of polyps.
15,16 For VCE, a new version of 
RAPID software (Given Imaging Ltd., Tokyo, Japan) has been 
installed in the FICE system, raising the possibility of improving 
the contrast of vascular and mucosal patterns.
17,18
Herein, we performed VCE using a capsule equipped with 
white-light light-emitting diodes (LED), hereinafter referred to 
as contrast image capsule endoscope (CICE). A specially selected 
white-light LED provides increased intensity of illumination in 
the blue range, which is the spectral range maximally absorbed 
by hemoglobin. The aim of this pilot study was to assess the Hatogai K, et al: Evaluating Polyposis Syndromes Using a Newly Developed CE  219
feasibility and efficacy of CICE for small bowel surveillance in 
patients with polyposis syndromes.
MATERIALS AND METHODS
1. CICE
The capsule is the same type as that of the Olympus EC Type 
1 (Olympus Medical Systems, Tokyo, Japan), but is equipped 
with white-light LED selected specifically to increase illumi-
nation intensity in the blue light range mainly absorbed by 
hemoglobin (Fig. 1). Contrast images are generated employing 
green and blue to make the blue-enhanced white-light LED ef-
fect more visible. Pre-contrast white-light images can also be 
created.
19 Contrast images and pre-contrast white-light images 
cannot be created simultaneously by the workstation; however, 
such that contrast images must be reconstructed using another 
computer after downloading the video. 
2. Patients and VCE procedure
This pilot study included 6 patients (5 men, 1 woman; mean 
age, 39.8 years; range, 25 to 64 years): 4 with familial adeno-
matous polyposis (FAP) and 1 each with Cowden syndrome (CS) 
and Cronkhite-Canada syndrome (CCS). All of the four patients 
with FAP, including a pair of brothers, were diagnosed by 
colonoscopy and/or duodenoscopy, their familial histories, and 
APC gene mutations. The case 4 was diagnosed CS by biopsy 
samples obtained from esophagus, stomach and colon, and also 
pathognomonic skin lesions. The case 5 patient was diagnosed 
as CCS by gastric and colonic hamartomatous polyps and typi-
cal clinical symptoms such as skin pigmentation, alopecia, and 
nail dystrophy. Written informed consent was obtained from 
all 6 patients. The VCE procedure was as follows. The patients 
swallowed the VCE device after a 12-hour fast with neither pre-
medication nor bowel preparation. Drinking and eating were 
permitted after 2 and 4 hours, respectively. The recorded digital 
information was downloaded from the recorder into the work-
station (WS-1; Olympus Medical Systems), and the images were 
analyzed using the appropriate software. Images were first as-
sessed routinely and then converted into contrast images using 
another computer.
For the purpose of assessing the distribution of small bowel 
polyps, the small bowel transit time was divided into 3 equal 
parts, creating tertiles (first, second, and third tertiles) as previ-
ously described.
20
3. Evaluations of CICE images
To compare the numbers of detected polyps between pre-con-
trast and contrast images, 2 endoscopists (K. H. and N. H.) read 
the same VCE record using pre-contrast and contrast images in 
alternate shifts. Next, to assess the additional effects of using 
contrast images, a 10-question, computer-based test consist-
ing of 10 images (5 adenomatous polyps and 5 hamartomatous 
polyps) was conducted. The participants were 5 novice endosco-
pists and 5 expert endoscopists. Novices by definition had less 
than 3 years of experience with endoscopy. Experts by defini-
tion had more than 10 years of experience with endoscopy. All 
participants were blinded to the patients’ clinical histories. At 
first, each participant judged whether polyps were adenoma-
tous or hamartomatous based on pre-contrast images. Next, 
each participant judged whether polyps were adenomatous or 
hamartomatous polyps based on contrast images. Finally, all 
participants scored each contrast image in comparison with the 
corresponding pre-contrast image, as previously reported.
18 In 
brief, the 10 pre-contrast polyp images (5 adenomatous polyps 
and 5 hamartomatous polyps) were presented to each partici-
pant in random order for comparison with the contrast images. 
Participants scored each of the pre-contrast and contrast images 
for visibility of the polyp according to the following scale: +2 
(improved visibility), +1 (somewhat improved visibility), 0 (visi-
bility equivalent to that of conventional CE visibility), -1 (some-
what decreased visibility), and -2 (decreased visibility). Scores of 
the 5 novice and the 5 expert endoscopists for each pre-contrast 
and contrast image were tallied. If an image earned a total score 
of 5 or more, the image was considered to be improved, a score 
between 4 and -4 points indicated no change, and a score of -5 
or less indicated decreased visibility. 
4. Statistical analysis
Statistical analysis was performed using the Mann-Whitney 
U test for non-normally distributed continuous variables, and 
Fisher’s exact test for non-continuous variables. A p-values 
less than 0.05 were considered significant. PASW version 17.0 
software (SPSS Inc., Tokyo, Japan) was used for all statistical 
analyses.
RESULTS
All capsules were excreted within 2 weeks, and no VCE-
Fig. 1. The principle of contrast image capsule endoscopy. A specially 
selected white-light light-emitting diode (LED) provides an increased 
intensity of illumination in the blue range, which is the spectral range 
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associated adverse events occurred in any of our cases. Total 
small intestinal surveillance was achieved in 4 of the 6 cases, 
but VCE did not reach the cecum during the observation period 
in 2 cases. All patients had gastric polyps. Though all patients 
with FAP had polyps only in the first tertile of the small bowel, 
those with CS or CCS had polyps in the first tertile as well as the 
second and/or third tertiles (Table 1).
Numbers of the detected polyps did not differ significantly 
between pre-contrast and contrast images (data was not shown). 
The accuracy rates of polyp diagnosis using pre-contrast and 
contrast images are shown in Table 2. There was no signifi-
cant difference between pre-contrast and contrast images in 
discriminating adenomatous from hamartomatous polyps. For 
expert endoscopists, the accuracy rate was increased with con-
trast images. On the other hand, for novices, the accuracy rate 
was decreased. Assessment of enhanced visibility using contrast 
images is shown in Table 3. All 10 polyps had equivalent or 
enhanced visibility on contrast images. Most notably, 50% of 
adenomatous polyps showed enhanced visibility on contrast 
images.
Representative images are shown in Figs 2 and 3. In pre-
contrast images, polyps in FAP patients were visualized as whit-
ish slightly elevated lesions with a centrally depressed area (Fig. 
2A). On the other hand, in contrast images, adenomatous and 
normal components were clearly distinguished as light green-
ish and brownish areas, respectively (Fig. 2B). Polyps associated 
with CS and CCS were visualized as spherical elevated lesions 
with atrophied villi, and the colors were a mixture of white and 
orange shades essentially the same as the surrounding normal 
mucosa in pre-contrast images (Fig. 3A). On contrast images, 
micro-structures of the polyps were visualized more clearly than 
in the pre-contrast images (Fig. 3B).  
Table 1. Patient Profiles and Polyp Distribution
Case Age Gender Disease
Conventional endoscopy Distribution of polyps
Stomach Colon First tertile Second tertile Third tertile
1 35 M FAP + NA + - -
2 38 F FAP + + + - -
3 25 M FAP + + + - -
4 28 M FAP + + + - -
5 4 9 M C S + + +++
6 64 M CCS + + + - +
FAP, familial adenomatous polyposis; CS, Cowden syndrome; CCS, Cronkhite-Canada syndrome; NA, not available.
Table 2. Mean Accuracy of Polyp Discrimination
Image type
p-value
Pre-contrast Contrast
Novice endoscopist 76% (38/50) 72% (36/50) 0.82
Experienced endoscopist 80% (40/50) 82% (41/50) 1.00
Total 78% (78/100) 77% (77/100) 1.00
Table 3. Evaluation of Visibility Using Contrast Images
Improved 
visibility
Equivalent
visibility
Decreased
visibility
Adenomatous polyp 50% (5/10) 50% (5/10) 0% (0/10)
Hamartomatous polyp 20% (2/10) 80% (8/10) 0% (0/10)
Total 35% (7/20) 65% (13/20) 0% (0/20)
Fig. 2. Contrast image capsule en-
doscopy images (A, pre-contrast; B, 
contrast) of small intestinal polyps 
were obtained in Case 1 with famil-
ial adenomatous polyposis. Adeno-
matous and normal components are 
clearly distinguished as light green-
ish and brownish areas, respectively. 
The micro-structures of the polyps 
are visualized more clearly in the 
contrast image than pre-contrast im-
age.Hatogai K, et al: Evaluating Polyposis Syndromes Using a Newly Developed CE  221
DISCUSSION
CICE was first reported by Aihara et al.
19 To our knowledge, 
this is the first pilot study to assess the feasibility of the newly 
developed CICE for small bowel surveillance in patients with 
polyposis syndromes. The major advantage of VCE is that in-
formation from the mid-gastrointestinal tract can be obtained 
without patient discomfort. We attempted to evaluate the 
distributions of polyps and to assess the efficacy of CICE for 
evaluating polyposis syndromes. The distributions of polyps in 3 
polyposis syndromes could be evaluated by CICE, as previously 
reported for VCE.
7-14 We conducted three evaluations to 1) de-
termine effects on numbers of the detected polyps, 2) compare 
polyp diagnostic rates between adenoma and hamartoma, and 3) 
assess polyp visibility. The numbers of the detected polyps did 
not differ significantly between pre-contrast and contrast im-
ages. This suggests that CICE is not appropriate as a screening 
procedure, such as for detecting polyps, but is suitable for in-
vestigating polyps which have already been detected. Accuracy 
rates of polyp diagnosis did not differ significantly between pre-
contrast and contrast images for discriminating adenomatous 
from hamartomatous polyps. We evaluated only 10 polyps, as-
sessed by 10 investigators. To confirm efficacy in discriminating 
adenomatous from hamartomatous polyps using CICE, further 
clinical study is necessary. Interestingly, for expert endoscopists, 
the accuracy rate was increased with contrast images. This was 
not the case for novice endoscopists. The CICE contrast im-
ages clearly demarcated lesions and improved the visibility of 
minute structures of adenomatous polyps in FAP cases by us-
ing a specialized white-light LED. All 10 polyps had equivalent 
or enhanced visibility when contrast images were employed. 
In particular, visibility was enhanced for 50% of adenomatous 
polyps on contrast images. Two major virtual chromoendoscopy 
techniques are now available, NBI and FICE. FICE is based on 
the bandwidth of the conventional endoscopic image narrowed 
down arithmetically using computerized spectral estimation 
technology.
17,18 NBI, on the other hand, is based on the presence 
of optical filters within the light source of the endoscope, which 
constrains the bandwidth of spectral estimation technology.
21 
FICE is classified as a digital image enhancement method, NBI 
as an optical-digital method.
22 Software can be installed in the 
FICE system without modification of the capsule, while NBI 
would require re-engineering of the capsule with incorporation 
of optical filters. As NBI is a real-time imaging technique, the 
capsule with optical filters can generate only NBI images. Thus, 
CICE was developed to obtain normal and hemoglobin enhanced 
images simultaneously using an LED selected to specifically 
increase illumination intensity in the blue light range mainly 
absorbed by hemoglobin. The CICE technique is classified as an 
optical-digital method, as noted above, making it different from 
FICE in terms of use of the selected LED. It also differs from NBI 
in that no optical filters are used. CICE has been evaluated in 
patients with obscure gastrointestinal bleeding and CD as well. 
The clinical benefit was not obvious for detection of angioma (10 
patients) but in 4 patients with CD, mucosal abnormalities were 
clearly seen due to the CICE technology.
23
This study has limitations. It was a pilot study of only 6 pa-
tients. We could not confirm that the diagnostic yield or detec-
tion rate of polyps obtained using contrast images was higher 
than values obtained using pre-contrast images. We found that 
CICE contrast images allowed clearer visualization than pre-
contrast images of the demarcation between adenomatous and 
normal components. In addition, CICE contrast images provided 
more minute structural details of lesions than pre-contrast im-
ages. This new technology can be adapted to maneuverable 
capsule endoscopy,
24,25 to allow precise diagnosis, like conven-
tional endoscopes with NBI or FICE, in the near future. 
In conclusion, CICE is an effective tool for enhancing visibil-
ity of polyps in the patients with polyposis syndrome. CICE is a 
novel, easy-to-apply imaging tool that is equipped with LED se-
lected specifically for the main absorption range of hemoglobin.   
Further clinical trials are needed to confirm the efficacy of this 
new device.
Fig. 3. Contrast image capsule en-
doscopy (A, pre-contrast; B, contrast) 
and narrow band imaging images of 
small intestinal polyps were obtained 
in Case 5 with Cowden syndrome. 
The micro-structures are more clear-
ly visualized in the contrast image.222  Gut and Liver, Vol. 6, No. 2, April 2012
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